Scranton Enterprises News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BARCELONA (Reuters) -Spanish drug maker Grifols' top executive Thomas Glanzmann said on Thursday he will become non-executive chairman in 2025 as part of the beleaguered company's management overhaul. Glanzmann, who is currently both chief executive and executive chairman, had said earlier this month he would leave the CEO job on April 1, but remain executive chairman afterwards. Grifols shares on Spain's blue-chip index <.IBEX> were down 6.5% to 10.9 euros per share shortly after Glanzmann's announcement, regaining some of the ground lost earlier in the day whe...

Radiocor. Finanza. Morning note: economia e finanza dai giornali esteri.

Short-seller fund Gotham City Research on Tuesday issued a second report on Spanish pharmaceutical company Grifols maintaining some of the questions over its accounting practices. Gotham...

CSL’s rival Grifols is taking its short-seller, Gotham City, to court saying the “defendants crossed the line”.

/PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is...